Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
NCT07593248
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
2000
Enrollment
INDUSTRY
Sponsor class
Conditions
Lung Cancer
Sponsor
AstraZeneca